−1.51USD
−70.69 MUSD
110.32 MUSD
39.41 M
About Arcellx, Inc.
Sector
Industry
CEO
Rami Elghandour
Website
Headquarters
Gaithersburg
Employees (FY)
130
Founded
2014
ISIN
US03940C1009
FIGI
BBG00QHJM4S9
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ACLX is 55.40 USD — it has decreased by 2.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arcellx, Inc. stocks are traded under the ticker ACLX.
Arcellx, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Arcellx, Inc. has a max estimate of 87.00 USD and a min estimate of 73.00 USD.
ACLX earnings for the last quarter are −0.81 USD whereas the estimation was −0.55 USD which accounts for −47.40% surprise. Estimated earnings for the next quarter are −0.53 USD. See more details about Arcellx, Inc. earnings.
Arcellx, Inc. revenue for the last quarter amounts to 14.96 M USD despite the estimated figure of 17.49 M USD. In the next quarter revenue is expected to reach 20.07 M USD.
Yes, you can track Arcellx, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ACLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arcellx, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 130.00 employees. See our rating of the largest employees — is Arcellx, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arcellx, Inc. EBITDA is −87.27 M USD, and current EBITDA margin is −79.62%. See more stats in Arcellx, Inc. financial statements.